Latest Blog Posts Tagged "Research News"
January 17, 2017
Sarkis Mazmanian, PhD, of CalTech discusses what we know about the gut bacteria and Parkinson's connection in our "Getting to a Cure: The Science behind the Search" podcast series.
December 28, 2016
The Foundation is funding a clinical trial led by a team at Emory University and Hygieia Sciences, LLC, to define a Parkinson's-specific "breath fingerprint."
December 23, 2016
Some of our on-staff PhDs reflect on the work in 2016 that brought us closer to our goal of a world without Parkinson's disease.
December 20, 2016
Herantis Pharma was awarded a $6M grant to study the safety and efficacy of a potential therapy for Parkinson's disease (PD): cerebral dopamine neurotrophic factor (CDNF).
December 08, 2016
Voyager Therapeutics announced results from a trial, supported in early stages by MJFF, to help the brain convert levodopa to dopamine and better control motor symptoms.
December 06, 2016
Rachel Dolhun, MD, and Brian Fiske, PhD, give an overview of the promising Parkinson's research updates made in 2016.
December 02, 2016
A team from CalTech proposes a connection between gut bacteria, fatty acids, brain inflammation and Parkinson's symptoms.
December 01, 2016
Two recently published studies, one MJFF-funded, point to mutations in the GBA gene that may predispose some to cognitive problems with Parkinson's disease.
November 29, 2016
Tools developed by the winners from UC San Francisco and Weill Cornell Medicine could accelerate testing of new Parkinson's treatments by helping researchers design trials and choose study volunteers.
November 10, 2016
The trial showed the therapy is safe and tolerable and that the drug gets into the central nervous system well and reduces levels of alpha-synuclein in blood serum. Phase II expected to begin in 2017.